Efficacy News and Research

RSS
Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

FDA approves CorMatrix ECM for Pericardial Closure

FDA approves CorMatrix ECM for Pericardial Closure

NanoBio Corporation to present Nanoemulsion Phase I clinical trial data at ICAAC Conference

NanoBio Corporation to present Nanoemulsion Phase I clinical trial data at ICAAC Conference

Genmab announces Phase II ofatumumab study results in RRMS patients

Genmab announces Phase II ofatumumab study results in RRMS patients

More men than women discontinue medications due to side effects

More men than women discontinue medications due to side effects

Instem announces Centrus Solution Suite for enterprise information integration in early drug development

Instem announces Centrus Solution Suite for enterprise information integration in early drug development

Ortho Biotech unblinded abiraterone acetate Phase 3 study for prostate cancer patients

Ortho Biotech unblinded abiraterone acetate Phase 3 study for prostate cancer patients

Campaign for Tobacco-Free Kids applauds FDA for action against electronic cigarette distributors

Campaign for Tobacco-Free Kids applauds FDA for action against electronic cigarette distributors

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

WHO regional meeting in South-East Asia addresses antimicrobial resistance, developing country access to medical devices

WHO regional meeting in South-East Asia addresses antimicrobial resistance, developing country access to medical devices

Numerate awarded new contract by Defense Threat Reduction Agency

Numerate awarded new contract by Defense Threat Reduction Agency

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Special journal issue highlights obsessive compulsive disorder and Tourette's disorder therapies

Special journal issue highlights obsessive compulsive disorder and Tourette's disorder therapies

AAOS releases clinical practice guideline for periprosthetic joint infection diagnosis

AAOS releases clinical practice guideline for periprosthetic joint infection diagnosis

ASNM to hold annual conference on nanomedicine

ASNM to hold annual conference on nanomedicine

FerroKin BioSciences initiates international Phase 2 study of FBS0701

FerroKin BioSciences initiates international Phase 2 study of FBS0701

Allos Therapeutics to present FOLOTYN trial results at ESMO Congress

Allos Therapeutics to present FOLOTYN trial results at ESMO Congress

Oxygen Biotherapeutics 2010 first quarter net loss increases to $3 million

Oxygen Biotherapeutics 2010 first quarter net loss increases to $3 million

Seaside reports positive data from STX209 Phase 2 study in ASD

Seaside reports positive data from STX209 Phase 2 study in ASD

CombinatoRx is now Zalicus

CombinatoRx is now Zalicus

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.